Antibiotic partnership plans accelerated drug development

B2201157-Tuberculosis_bacteria-SPL_300tb

Source: © A Dowsett, Public Health England / Science Photo Library

Public–private venture will invest $350 million over five years but there are warnings that much more money is still needed